INDIGO Home University of Illinois at Urbana-Champaign logo uic building uic pavilion uic student center

Inclusion, Analysis, and Reporting of Sex and Race/Ethnicity in Clinical Trials: Have We Made Progress?

Show simple item record

Bookmark or cite this item: http://hdl.handle.net/10027/7891

Files in this item

File Description Format
PDF jwh.2010.2469.pdf (146KB) (no description provided) PDF
Title: Inclusion, Analysis, and Reporting of Sex and Race/Ethnicity in Clinical Trials: Have We Made Progress?
Author(s): Geller, Stacie E.; Koch, Abby; Pellettieri, Beth; Carnes, Molly
Subject(s): compliance trials
Abstract: Background: The National Institutes of Health (NIH) Revitalization Act of 1993 requires that NIH-funded clinical trials include women and minorities as participants; other federal agencies have adopted similar guidelines. The objective of this study is to determine the current level of compliance with these guidelines for the inclusion, analysis, and reporting of sex and race/ethnicity in federally funded randomized controlled trials (RCTs) and to compare the current level of compliance with that from 2004, which was reported previously. Methods: RCTs published in nine prominent medical journals in 2009 were identified by PubMed search. Studies where individuals were not the unit of analysis, those begun before 1994, and those not receiving federal funding were excluded. PubMed search located 512 published articles. After exclusion of ineligible articles, 86 (17%) remained for analysis. Results: Thirty studies were sex specific. The median enrollment of women in the 56 studies that included both men and women was 37%. Seventy-five percent of the studies did not report any outcomes by sex, including 9 studies reporting <20% women enrolled. Among all 86 studies, 21% did not report sample sizes by racial and ethnic groups, and 64% did not provide any analysis by racial or ethnic groups. Only 3 studies indicated that the generalizability of their results may be limited by lack of diversity among those studied. There were no statistically significant changes in inclusion or reporting of sex or race/ethnicity when compared with 2004. Conclusions: Ensuring enhanced inclusion, analysis, and reporting of sex and race/ethnicity entails the efforts of NIH, journal editors, and the researchers themselves.
Issue Date: 2011-03-15
Publisher: Mary Ann Liebert
Citation Info: Geller, S. E., Koch, A., Pellettieri, B., & Carnes, M. 2011. Inclusion, Analysis, and Reporting of Sex and Race/Ethnicity in Clinical Trials: Have We Made Progress? Journal of Women's Health. March 2011, 20(3): 315-320. DOI: 10.1089/jwh.2010.2469.
Type: Article
Description: This is a copy of an article published in the Journal of Womens Health © 2011 [copyright Mary Ann Liebert, Inc.]; Journal of Womens Health is available online at: http://www.liebertonline.com. DOI: 10.1089/jwh.2010.2469
URI: http://hdl.handle.net/10027/7891
ISSN: 1540-9996
Date Available in INDIGO: 2011-08-31
 

This item appears in the following Collection(s)

Show simple item record

Statistics

Country Code Views
United States of America 133
China 29
United Kingdom 14
Germany 7
France 7

Browse

My Account

Information

Access Key